SEC Company Response from Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097) (ENTX) — Jan 19, 2018
Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097)
Date: Jan. 19, 2018 · CIK: 0001638097 · Accession: 0000950103-18-000612
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-221472
Letter
Oppenheimer & Co. Inc.
85 Broad Street
New York, NY 10004
January 19, 2018
VIA EDGAR
United States Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Re: Entera Bio Ltd.
Registration Statement on Form F-1, as amended
File No. 333-221472
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Oppenheimer & Co. Inc., as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on January 23, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with, or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very
truly yours,
Oppenheimer
& Co. Inc.
Show Raw Text
CORRESP
1
filename1.htm
Oppenheimer
& Co. Inc.
85 Broad Street
New
York, NY 10004
January
19, 2018
VIA
EDGAR
United
States Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Re: Entera
Bio Ltd.
Registration
Statement on Form F-1, as amended
File
No. 333-221472
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, Oppenheimer & Co. Inc., as representative of the underwriters, hereby requests acceleration of the effective date
of the above-referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on January 23, 2018,
or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably
anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary
prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with, or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.
Very
truly yours,
Oppenheimer
& Co. Inc.
By: /s/
Michael Margolis
Name:
Michael Margolis
Title:
Managing Director